Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
20.02. | Basilea Pharmaceutica - From strength to strength | 374 | Edison Investment Research | FY23 was another strong year for Basilea, marked by successive guidance beats and meaningful progress in fortifying its product pipeline. Revenues of CHF157.6m were ahead of guidance, driven by c 23%... ► Artikel lesen | |
20.02. | Wilmington - Focus on governance, risk and compliance | 255 | Edison Investment Research | With November's purchase of Astutis, January's sale of MiExact and the proposed Healthcare business disposal, Wilmington is now firmly focused on opportunities within the large global governance, risk... ► Artikel lesen | |
20.02. | Pan African Resources - A happy valentine | 215 | Edison Investment Research | Pan African Resources' (PAF's) H124 results were released on 14 February, with earnings (and headline earnings) within 1.5% of our forecast and normalised headline earnings within 1.2% of our forecast... ► Artikel lesen | |
20.02. | Dentsu Group - Return to organic growth forecast for FY24 | 292 | Edison Investment Research | Dentsu's FY23 net revenue was a touch above guidance at Q3, with a better-than-expected operating margin reflecting a good Q4 in Japan, further boosted by a short delay in an IT project pushed out to... ► Artikel lesen | |
20.02. | Recce Pharmaceuticals - Supportive advancements on the pipeline | 245 | Edison Investment Research | Recce Pharmaceuticals has announced several positive developments in recent weeks relating to its therapeutic programmes, particularly for lead anti-infective candidate RECCE® 327 (R327). It entered... ► Artikel lesen | |
20.02. | Ultimovacs - Another ODD boosts the off-the-shelf, universal UV1 | 293 | Edison Investment Research | Ultimovacs has been granted Orphan Drug designation (ODD) from the European Medicines Agency (EMA) for UV1 in mesothelioma, marking another step forward for the clinical development of its lead universal... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 323 |
BAYER | 249 |
BYD | 169 |
NEL | 166 |
DEUTSCHE BANK | 162 |
TUI | 153 |
NVIDIA | 141 |
TESLA | 141 |
RHEINMETALL | 132 |
RWE | 132 |
PLUG POWER | 128 |
MERCEDES-BENZ | 123 |
APPLE | 118 |
DEUTSCHE LUFTHANSA | 112 |
SUPER MICRO COMPUTER | 112 |
BERKSHIRE HATHAWAY | 109 |
PALANTIR TECHNOLOGIES | 102 |
XIAOMI | 96 |
AMAZON | 93 |
VOLKSWAGEN | 92 |
AIXTRON SE | 89 |
BASF | 82 |
COMMERZBANK | 80 |
RENK GROUP | 80 |
SIEMENS ENERGY | 78 |